| doxycycline versus placebo | |||
| Mosorin, 2001 | Doxycycline 150 mg/d versus Placebo | double blind Follow-up duration: 18 mo | |
| endovascular repair versus open repair | |||
| OVER, 2009 NCT00094575 | endovascular repair versus open repair | men (aged >=49 years) with abdominal aortic aneurysms candidate for both both elective endovascular repair and open repair | open Follow-up duration: 1.8y USA |
| DREAM, 2005 NCT00421330 | elective endovascular repair versus conventional open repair | abdominal aortic aneurysm of at least 5 cm in diameter and who were considered suitable candidates for both techniques. | open Follow-up duration: 2 y (6 y) The Netherlands |
| EVAR trial 1, 2005 ISRCTN55703451 | endovascular aneurysm repair versus open repair | aneurysms of at least 5·5 cm in diameter | open Follow-up duration: 2.9 y (median) UK |
| endovascular repair versus surveillance | |||
| PIVOTAL (Ouriel), 2010 | early endovascular repair versus ultrasound surveillance | patients (13.3% women; mean age, 71 +/- 8 years) with 4 to 5 cm abdominal aortic aneurysms | open Follow-up duration: 20 months USA |
| EVAR trial 2, 2005 ISRCTN55703451 | Endovascular aneurysm repair versus No intervention | patients aged 60 years or older who had aneurysms of at least5·5 cm in diameter and of poor health status considered unfit for major surgery. | open Follow-up duration: 2.4 y (median) UK |
| roxithromycin versus placebo | |||
| Vammen, 2001 | Roxithromycin 300 mg/d versus Placebo | double blind Follow-up duration: 18 mo | |
-
About
-
Browse pathology
|
treatment
-
Site map
-
Credits
Made with in Lyon
-
Contact us
-
Privacy policy
-
